Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years.

Anas NajjarAbderrahman NajjarRafik Karaman

Published in: Molecules (Basel, Switzerland) (2020)

the prodrug approach has shown many successes and still remains a viable and effective approach to deliver new active agents. This conclusion is supported by the recent approved prodrugs and the scan of clinical trials conducted between 2013-2018.

Keyphrases

clinical trial
computed tomography
cancer therapy
randomized controlled trial
magnetic resonance imaging
phase ii
magnetic resonance
open label
drug delivery
phase iii
contrast enhanced